Live Breaking News & Updates on Harmony Bioscience

Stay updated with breaking news from Harmony bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript

HRMY earnings call for the period ending March 31, 2024. ....

United States , San Francisco , Raymond James , Graig Suvannavejh , Piper Sandler , Jeff Dayno , David Amsellem Piper Sandler , Sandip Kapadia , Corinne Jenkins , Jason Gerberry , Brisebois Oppenheimer , Graig Suvannavejh Mizuho , Luis Sanay , Kumar Budur , Charles Duncan Cantor Fitzgerald , Jeff Dierks , Charles Duncan , Corinne Jenkins Goldman Sachs , Fadia Needham , Francois Brisebois , Danielle Brill , Danielle Brill Raymond James , David Amsellem , Teijin Pharma , Scott Baraban , America Merrill Lynch ,

Axsome drug succeeds in narcolepsy symptoms trial

BioPharma ....

Joseph Thome , Bioscience Wakix , Drug Administration , Axsome Therapeutics , Jazz Pharmaceutical Xyrem , Harmony Bioscience ,

Pitolisant Granted Orphan Drug Status in Prader-Willi Syndrome

The FDA has granted Orphan Drug designation to Harmony Bioscience’s pitolisant for the treatment of Prader-Willi syndrome. ....

Kumar Budur , Drug Administration , Orphan Drug , Harmony Bioscience , Harmony Biosciences ,

Pitolisant May Improve Sleepiness in Myotonic Dystrophy Patients

Phase 2 study results reveal pitolisant significantly improved daytime sleepiness and fatigue in myotonic dystrophy type 1 patients. ....

Kumar Budur , Jeffreym Dayno , Myotonic Dystrophy Health Index , Harmony Bioscience , Harmony Biosciences , Daytime Sleepiness Scale , Epworth Sleepiness Scale , Clinical Global Impression , Fatigue Severity , Fatigue Severity Scale , Open Label Extension ,

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Forecasted to Post FY2024 Earnings of $2.90 Per Share

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) – Equities research analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a research report issued to clients and investors on Wednesday, November 1st. Cantor Fitzgerald analyst C. Duncan now forecasts that the company will post earnings per share of […] ....

United States , Piper Sandler , Raymond James , Cantor Fitzgerald , Goldman Sachs Group , Platinum Investment Management Ltd , China Universal Asset Management Co , Life Insurance Co , Lazard Asset Management , Harmony Biosciences Holdings Inc , Berenberg Bank , Harmony Biosciences Company Profile , Quadrant Capital Group , Harmony Biosciences Holdings , Free Report , Harmony Biosciences , Harmony Bioscience , Get Free Report , Capital Group , Investment Management , Universal Asset Management , Asset Management , Biosciences Holdings , Harmony Biosciences Daily , Nasdaq Hrmy , Earnings Estimates ,